World's Best Scientists 2026 revealed!
Isabelle Boutron

Isabelle Boutron

D-Index & Metrics

Medicine

D-Index
85
Citations
226718
World Ranking
14322
National Ranking
459

Overview

Isabelle Boutron is affiliated with Université Paris Cité in France, with a research focus primarily in the field of Medicine. Their scholarly work spans multiple subfields including Statistics, Probability and Uncertainty; Public Health, Environmental and Occupational Health; Economics and Econometrics; Sociology and Political Science; and Infectious Diseases.

The main topics covered in Boutron's research include Meta-analysis and systematic reviews, Health Systems, Economic Evaluations, and Quality of Life, as well as the Delphi Technique in Research. Additional areas of study include Academic Publishing and Open Access, Health and Medical Research Impacts, Ethics in Clinical Research, and Clinical practice guidelines implementation.

Among the frequent collaborators are Philippe Ravaud, Asbjørn Hróbjartsson, Anna Chaimani, Joerg J Meerpohl, and David Tovey, each of whom has coauthored numerous publications with Boutron.

The researcher has published significantly in venues such as Zenodo (CERN European Organization for Nuclear Research), Journal of Clinical Epidemiology, OPAL (Open@LaTrobe) (La Trobe University), BMJ, and BMJ Open.

Recent notable publications include:

  • The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, 2021, BMJ
  • The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, 2021, Systematic Reviews
  • The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, 2021, International Journal of Surgery
  • PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews, 2021, BMJ
  • The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, 2021, PLoS Medicine

Best Publications

  • The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

    Matthew J Page;Joanne E McKenzie;Patrick M Bossuyt;Isabelle Boutron

  • ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

    Jonathan A. C. Sterne;Miguel A Hernan;Barnaby C Reeves;Jelena Savovic;Jelena Savovic

  • RoB 2: a revised tool for assessing risk of bias in randomised trials.

    Jonathan A.C. Sterne;Jelena Savović;Jelena Savović;Matthew J. Page;Roy G. Elbers

  • Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide

    Tammy C Hoffmann;Paul P Glasziou;Isabelle Boutron;Ruairidh Milne

  • PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.

    Matthew J Page;David Moher;Patrick M Bossuyt;Isabelle Boutron

  • The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

    Brian Hutton;Georgia Salanti;Deborah M Caldwell;Anna Chaimani

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • No surgical innovation without evaluation: the IDEAL recommendations.

    Peter McCulloch;Douglas G Altman;W Bruce Campbell;David R Flum

  • Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

    Matthew J Page;Joanne E McKenzie;Patrick M Bossuyt;Isabelle Boutron

  • Reducing waste from incomplete or unusable reports of biomedical research

    Paul Glasziou;Douglas G Altman;Patrick Bossuyt;Isabelle Boutron

  • CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

    Isabelle Boutron;Douglas G Altman;David Moher;Kenneth F Schulz

  • A revised tool for assessing risk of bias in randomized trials

    Julian Pt Higgins;Jonathan Ac Sterne;Jelena Savovic;Matthew J Page

  • Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

    Isabelle Boutron;Susan Dutton;Philippe Ravaud;Douglas G. Altman

  • Comparison of registered and published primary outcomes in randomized controlled trials.

    Sylvain Mathieu;Isabelle Boutron;David Moher;Douglas G. Altman

  • Challenges in evaluating surgical innovation.

    P L Ergina;P L Ergina;J A Cook;J M Blazeby;I Boutron

  • Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • Influence of trial sample size on treatment effect estimates: meta-epidemiological study

    Agnes Dechartres;Agnes Dechartres;Ludovic Trinquart;Ludovic Trinquart;Isabelle Boutron;Philippe Ravaud

  • CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials

    K F Schulz;D G Altman;D Moher;D Moher;V Barbour

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration

    I Boutron;D Moher;D G Altman;K F Schulz

  • WITHDRAWN: Methods and processes of the CONSORT group: Example of an extension for trials assessing nonpharmacologic treatments

    Isabelle Boutron;David Moher;Douglas G. Altman;Kenneth F. Schulz

Frequent Co-Authors

Philippe Ravaud
Philippe Ravaud Université Paris Cité
Douglas G. Altman
Douglas G. Altman University of Oxford
Raphaël Porcher
Raphaël Porcher Université Paris Cité
Sally Hopewell
Sally Hopewell University of Oxford
David Moher
David Moher Ottawa Hospital
Patrick M.M. Bossuyt
Patrick M.M. Bossuyt University of Amsterdam
Julian P T Higgins
Julian P T Higgins University of Bristol
Jonathan A C Sterne
Jonathan A C Sterne University of Bristol
Paul Glasziou
Paul Glasziou Bond University
Luc Mouthon
Luc Mouthon Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medicine but seeking alternative or supportive career options? There are plenty of affordable, flexible online programs that can prepare you for in-demand roles in the healthcare field.

For those drawn to medical records and patient data management, accredited rhia certification programs online offer a convenient way to qualify for Registered Health Information Administrator certification. This pathway lets you work in diverse healthcare settings, ensuring the security and quality of health information.

If you're detail-oriented and enjoy working with healthcare data, consider enrolling in a medical coding certification online. Certified billing and coding professionals are vital to the insurance and reimbursement process for clinics, hospitals, and providers.

Nursing continues to be one of the most versatile and high-demand fields. Prospective nurse practitioners can explore cheapest nurse practitioner programs to gain advanced clinical expertise and expanded career options. For nurses aiming for career advancement, cheapest online msn programs provide a pathway to leadership, education, and specialized practice—all while balancing work and study.

Best Scientists Citing Isabelle Boutron

Trending Scientists